[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0312165A - Utilização da taurina para o tratamento da alopecia - Google Patents

Utilização da taurina para o tratamento da alopecia

Info

Publication number
BR0312165A
BR0312165A BR0312165-8A BR0312165A BR0312165A BR 0312165 A BR0312165 A BR 0312165A BR 0312165 A BR0312165 A BR 0312165A BR 0312165 A BR0312165 A BR 0312165A
Authority
BR
Brazil
Prior art keywords
alopecia
taurine
treatment
oral composition
hypotaurin
Prior art date
Application number
BR0312165-8A
Other languages
English (en)
Inventor
Albert Duranton
Lionel Breton
Original Assignee
Oreal L Oreal S A L
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0207764A external-priority patent/FR2841101B1/fr
Priority claimed from FR0207765A external-priority patent/FR2841102B1/fr
Priority claimed from FR0207763A external-priority patent/FR2841128B1/fr
Application filed by Oreal L Oreal S A L, Nestec Sa filed Critical Oreal L Oreal S A L
Publication of BR0312165A publication Critical patent/BR0312165A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

"UTILIZAçãO DA TAURINA PARA O TRATAMENTO DA ALOPECIA". A presente invenção refere-se à utilização da taurina e/ou da hipotaurina e/ou de seus sais aceitáveis em uma composição oral, para a preparação de uma composição oral útil no tratamento e a prevenção do envelhecimento da unidade pilo-sebácea e/ou da alopecia.
BR0312165-8A 2002-06-21 2003-06-23 Utilização da taurina para o tratamento da alopecia BR0312165A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0207764A FR2841101B1 (fr) 2002-06-21 2002-06-21 Utilisation d'acides gras pour la preparation de complements alimentaires utiles dans le traitement des desordres de l'unite pilo-sebacee
FR0207765A FR2841102B1 (fr) 2002-06-21 2002-06-21 Utilisation de polyphenols pour la preparation de complements alimentaires utiles dans le traitement des desordres de l'unite pilo-sebacee
FR0207763A FR2841128B1 (fr) 2002-06-21 2002-06-21 Utilisation pour le traitement oral de l'alopecie de taurine ou d'hypotaurine et compositions en comportant
PCT/FR2003/001919 WO2004000293A2 (fr) 2002-06-21 2003-06-23 Utilisation de la taurine ou de derives pour le traitement de l'alopecie

Publications (1)

Publication Number Publication Date
BR0312165A true BR0312165A (pt) 2005-03-29

Family

ID=30003506

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0312165-8A BR0312165A (pt) 2002-06-21 2003-06-23 Utilização da taurina para o tratamento da alopecia

Country Status (10)

Country Link
US (1) US9138408B2 (pt)
EP (2) EP1515712B1 (pt)
JP (1) JP5041664B2 (pt)
CN (1) CN1662229B (pt)
AU (1) AU2003253075B2 (pt)
BR (1) BR0312165A (pt)
CA (1) CA2489308C (pt)
ES (1) ES2774911T3 (pt)
MX (1) MXPA04012641A (pt)
WO (1) WO2004000293A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1553851A2 (en) * 2002-10-16 2005-07-20 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals
FR2882895B1 (fr) * 2005-03-11 2009-02-13 Larena Sa Composition alimentaire a usage ophtalmique
FR2888725B1 (fr) * 2005-07-19 2007-09-21 Physcience Soc Par Actions Sim Complement alimentaire et son utilisation pour la prevention ou la lutte contre les effets de l'alopecie androgenique, de l'hyperseborrhee et de l'acne
WO2007099560A2 (en) * 2006-03-02 2007-09-07 Promed Exports Pvt. Ltd. Method for identification and quantification of polyherbal formulation ingredients
EP2036552B1 (en) 2006-07-05 2018-08-08 Kao Corporation Senescence inhibitor
JP5507802B2 (ja) * 2006-08-10 2014-05-28 花王株式会社 筋肉老化抑制剤
FR2905597B1 (fr) * 2006-09-12 2008-10-17 Oreal L' Procede d'elimination de l'odeur retenue par les matieres keratiniques au contact d'une eau traitee par un desinfectant halogene
FR2907000B1 (fr) * 2006-10-13 2008-12-26 Gervais Danone Sa Nouvelle composition et ses applications,notamment cosmetiques,pour traiter la deshydratation de la peau
DE102006050398A1 (de) * 2006-10-20 2008-04-24 Henkel Kgaa Kosmetisches Mittel enthaltend Purin und/oder Purinderivat und Taurin
MX2011004482A (es) * 2008-11-03 2011-05-31 Giuliani Spa Uso terapeutico, dietetico o cosmetico de compuestos con actividad anti-apoptotica especifica hacia caspasa-3, y composiciones que contienen estos compuestos.
WO2010064203A1 (en) 2008-12-02 2010-06-10 L'oreal Combination of reduced glutathione and amino acids for improving the quality of the hair in women
EP2255782A1 (en) * 2009-05-25 2010-12-01 Keune Haircosmetics Manufacturing B.V. Composition for the prevention or treatment of hair loss, and method of preparation
FR2953722B1 (fr) 2009-12-16 2012-03-09 Expanscience Lab Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
ES2614878T3 (es) * 2010-06-01 2017-06-02 Geistlich Pharma Ag Métodos y composiciones para terapia farmacéutica oral
FR2973234A1 (fr) * 2011-03-31 2012-10-05 Oreal Utilisation cosmetique d'inhibiteur d'arginase, comme agent pour freiner la chute des cheveux, des sourcils et/ou des cils
EP2739280B1 (en) * 2011-07-19 2020-09-09 Indus Biotech Private Limited A method of managing chemotherapy induced alopecia or cachexia or both
FR2982150B1 (fr) 2011-11-09 2016-05-20 Oreal Acide gras mono-insature pour le soin des ongles
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
FR3005410A1 (fr) * 2013-05-07 2014-11-14 Inneov Lab Association d'acide petroselinique et de zinc pour une administration par voie orale pour lutter contre le vieillissement des cheveux
FR3005412A1 (fr) * 2013-05-07 2014-11-14 Inneov Lab Association d'acide petroselinique et de taurine pour une administration par voie orale pour lutter contre le vieillissement des cheveux
FR3005411B1 (fr) 2013-05-07 2016-09-30 Laboratoires Inneov Association d'actifs pour une administration par voie orale pour ameliorer la qualite des ongles.
FR3009955B1 (fr) 2013-08-30 2016-11-25 Laboratoires Inneov Composition a base d'acide gras polyinsature et de vitamine d destinee a une administration par voie orale pour ameliorer la qualite de la chevelure
FR3014688B1 (fr) * 2013-12-12 2016-12-16 Laboratoires Inneov S N C Composition a base d'acide gras polyinsature et de carotenoide destinee a une administration par voie orale pour ameliorer la qualite de la chevelure
CN104857177A (zh) * 2014-02-24 2015-08-26 上海兰蒂斯生物医药科技有限公司 原花青素在制备预防或治疗因化疗引起脱发药物中的应用
FR3032612B1 (fr) * 2015-02-13 2017-02-24 Laboratoires Inneov Utilisation d'une association de taurine ou un de ses derives, de biotine et d'extrait de raisins pour lutter contre les cheveux fins
US11160759B1 (en) * 2015-10-09 2021-11-02 Combocap, Inc. Capsule with internal diaphragm for improved bioavailability
CN112516123B (zh) * 2015-12-25 2022-07-19 北京乳凝创智生物技术研发中心（有限合伙） 一种保健品外用制剂
EP3235490A1 (en) * 2016-04-18 2017-10-25 L'Oréal Composition for improving hair quality

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US459812A (en) 1891-09-22 Wood-bundling machine
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
FR2504535B1 (fr) 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
FR2581542B1 (fr) 1985-05-07 1988-02-19 Oreal Compositions topiques destinees au traitement de la peau a base de derives de l'acide salicylique
GB8519416D0 (en) 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
JPS6284021A (ja) 1985-10-08 1987-04-17 Shiseido Co Ltd テストステロン−５α−レダクタ−ゼ阻害剤
IT1218115B (it) 1986-05-14 1990-04-12 Magis Kema Impiego dell'acido 2 amino etansolfonico (taurina) in campo cosmetico e parafarmaceutico
GB8630721D0 (en) 1986-12-23 1987-02-04 Unilever Plc Cosmetic compositions
GB8806892D0 (en) 1988-03-23 1988-04-27 Unilever Plc Lactams their synthesis & use in cosmetic compositions
LU87304A1 (fr) 1988-07-29 1990-02-07 Oreal Nouveaux derives d'ureylene triamino-2,4,6 pyrimidine oxyde-3,leur preparation et leur utilisation en cosmetique et dermopharmacie
LU87308A1 (fr) 1988-08-01 1990-03-13 Oreal Nouveaux derives de diamino-2,4 pyrimidine oxyde-3 et leur utilisation pour le traitement et la prevention de la chute des cheveux
GB8830019D0 (en) 1988-12-22 1989-02-15 Unilever Plc Cosmetic composition
US6294520B1 (en) 1989-03-27 2001-09-25 Albert T. Naito Material for passage through the blood-brain barrier
GB8913708D0 (en) 1989-06-14 1989-08-02 Unilever Plc Cosmetic composition
ES2063309T3 (es) 1989-07-12 1995-01-01 Oreal Derivados de pirimidina 3-oxido halogenados, su utilizacion para el tratamiento y la prevencion de la caida de los cabellos y para estimular su crecimiento.
FR2651122B1 (fr) 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
FR2662607B1 (fr) 1990-05-30 1992-08-28 Oreal Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
FR2668928A1 (fr) * 1990-11-12 1992-05-15 Sederma Sa Utilisation de l'homotaurine en cosmetique pour les soins du cuir chevelu et la stimulation de la croissance des cheveux.
FR2677884B1 (fr) 1991-06-20 1993-07-09 Oreal Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
FR2678929A1 (fr) 1991-07-11 1993-01-15 Oreal Compositions pour freiner la chute des cheveux et pour induire et stimuler leur croissance a base de derives de 2,4-diamino pyrimidine 3-oxyde, nouveaux derives 2,4-diamino pyrimidine 3-oxyde.
JPH0680964A (ja) * 1991-12-27 1994-03-22 Sogo Yatsukou Kk 活性酸素消去剤
TW233264B (pt) * 1992-02-03 1994-11-01 Otsuka Pharma Co Ltd
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US6344448B1 (en) * 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
US5571783A (en) 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
US5700782A (en) * 1993-05-28 1997-12-23 Abbott Laboratories Enteral nutritional product
US5648377A (en) * 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
JPH07233046A (ja) 1993-12-28 1995-09-05 Kose Corp 外用剤
ES2171535T3 (es) * 1994-04-01 2002-09-16 Abbott Lab Producto nutritivo utilizado en el tratamiento de la colitis ulcerosa y su uso.
US6126940A (en) * 1994-06-30 2000-10-03 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent comprised of proanthocyanidins
JPH0873350A (ja) * 1994-09-06 1996-03-19 Itouen:Kk 脳機能改善剤、食品及び飲料
US5582839A (en) * 1995-04-18 1996-12-10 Nutrition 21 Magnesium taurate and other mineral taurates
MC2394A1 (fr) * 1995-05-24 1996-07-26 Mollet Marc Composition destinée à stopper la chute et/ou à favoriser
US5639785A (en) * 1995-06-07 1997-06-17 Global Pharma, Ltd. Methods for the treatment of baldness and gray hair using isoflavonoid derivatives
JP3792272B2 (ja) * 1995-06-13 2006-07-05 株式会社 伊藤園 体内中の酢酸及びアセトンの代謝促進剤
JP3396009B2 (ja) * 1995-10-17 2003-04-14 雪印乳業株式会社 低う蝕性栄養組成物
AU4383196A (en) * 1996-01-17 1997-08-11 Friedrich Kisters Amino acid preparation for stimulating hair growth
JPH107553A (ja) 1996-03-21 1998-01-13 Toutoushiyu Seizo Kk 生体内ラジカル消去剤及び抗潰瘍剤
JP3388678B2 (ja) 1996-07-11 2003-03-24 森永乳業株式会社 免疫賦活流動食品
US5895652A (en) * 1996-07-29 1999-04-20 Longevity Institute International Method of metabolic adjuvanation and cellular repair
JP3552856B2 (ja) 1996-09-27 2004-08-11 雪印乳業株式会社 栄養強化組成物
IL120128A0 (en) 1997-02-03 1997-06-10 Barr Ehud Compositions for the treatment of androgenetic alopecia and hirsutism
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6576660B1 (en) * 1997-10-31 2003-06-10 Arch Development Corporation Methods and compositions for regulation of 5-α-reductase activity
US20030153541A1 (en) * 1997-10-31 2003-08-14 Robert Dudley Novel anticholesterol compositions and method for using same
US6696484B2 (en) * 1997-10-31 2004-02-24 University Of Chicago Office Of Technology And Intellectual Property Method and compositions for regulation of 5-alpha reductase activity
US6149932A (en) * 1998-03-24 2000-11-21 Stabar Enterprises, Inc. Dietary supplement for preventing or reducing shedding of hair
JPH11292753A (ja) 1998-04-14 1999-10-26 Dowa Yakushou Kk 頭部皮膚外用剤
JPH11332514A (ja) * 1998-05-22 1999-12-07 Nof Corp バランス栄養食品
EP1100517A1 (en) * 1998-08-04 2001-05-23 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
ATE293981T1 (de) 1998-09-21 2005-05-15 Amato Pharm Prod Ltd System zur oralen wirkstoffabgabe zur steigerung der bioverfügbarkeit von aktiviertem glycyrrhetin
SE9803277D0 (sv) 1998-09-25 1998-09-25 Astra Pharma Prod Novel compounds
AT411958B8 (de) * 1998-11-19 2004-09-27 Jhs Privatstiftung Erfrischungsgetränk zur steigerung der alkohol-abbau-kapazität
US6261589B1 (en) * 1999-03-02 2001-07-17 Durk Pearson Dietary supplement nutrient soft drink composition with psychoactive effect
US6428818B1 (en) * 1999-03-30 2002-08-06 Purdue Research Foundation Tea catechin formulations and processes for making same
US6103272A (en) * 1999-07-15 2000-08-15 Keeney; Joseph A. Compositions for stimulating hair growth, preventing hair loss, or minimizing hair loss, and methods for preparing and using same
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6685970B1 (en) * 1999-09-21 2004-02-03 Kyowa Hakko Kogyo Co., Ltd. Compositions containing proanthocyanidin and a vitamin B6 derivative or a salt thereof
FR2803749B1 (fr) * 2000-01-18 2006-09-22 Pharmascience Lab Utilisation d'au moins un ester gras pour la preparation d'une composition destinee a inhiber l'activite de la 5 alpha-reductase, en pharmacie notamment en dermatologie, en cosmetique et en tant qu'additif alimentaire
NL1014380C2 (nl) 2000-02-14 2001-08-15 Friesland Brands Bv Darmwandversterkend voedingsmiddel.
JP4574788B2 (ja) * 2000-03-24 2010-11-04 協和発酵バイオ株式会社 プロアントシアニジン含有組成物
KR100402418B1 (ko) 2000-03-28 2003-10-22 한국식품개발연구원 유기산을 이용한 무취화 및 청징화된 양파음료의제조방법
JP2002003371A (ja) 2000-06-21 2002-01-09 Shiseido Co Ltd ステロイド５α−リダクターゼ活性阻害剤及びそれを有効成分とする医療用組成物、化粧料組成物、養毛料、皮膚障害治療剤
RU2165719C1 (ru) * 2000-07-07 2001-04-27 Открытое акционерное общество "Уссурийский бальзам" Биологически активная добавка к пище
FR2811567B1 (fr) * 2000-07-13 2003-01-17 Oreal Composition, notamment cosmetique, comprenant la dhea et/ou un precurseur ou derive de celle-ci, en association avec au moins un inhibiteur de no-synthase
JP2002097116A (ja) * 2000-09-19 2002-04-02 Shiseido Co Ltd 細胞賦活剤
KR20010000741A (ko) * 2000-10-17 2001-01-05 최성곤 유소아용 건강보조음료 조성물 및 그의 제조방법
IT1320080B1 (it) 2000-10-25 2003-11-18 Giuliani Spa Composizione per uso farmaceutico o dietetico.
JP2002128651A (ja) 2000-10-25 2002-05-09 Kose Corp 光老化抑制剤およびそれを含有することを特徴とする皮膚外用剤
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
JP2002330748A (ja) * 2001-05-07 2002-11-19 Sanehiro Nakamura 栄養素入り焼酎割り炭酸飲料
CN1322552A (zh) * 2001-05-16 2001-11-21 上海第二医科大学三叶科技公司 以β－胡萝卜素为主的抗氧化复合配方及工艺
GB0113348D0 (en) * 2001-06-01 2001-07-25 Mars Uk Ltd Skin diet
GB2381451A (en) 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
KR20020041348A (ko) * 2002-02-28 2002-06-01 이성희 면역기능을 강화시킨 바이오 홀몬파워 제조
DE20204844U1 (de) * 2002-03-26 2002-07-04 Weber & Weber GmbH & Co. KG, 82266 Inning Mikronährstoffkombinationsprodukt, geeignet für die nutritive Ergänzung bei einem erhöhten Bedarf an Mikronährstoffen, insbesondere bei Personen mit Herz-Kreislauf-Erkrankungen
EP1553851A2 (en) * 2002-10-16 2005-07-20 L'oreal Cosmetic composition for preventing and/or correcting the functional disorders of the pilo-sebaceous unit of mammals

Also Published As

Publication number Publication date
WO2004000293A3 (fr) 2004-05-13
CN1662229B (zh) 2010-05-26
CA2489308A1 (fr) 2003-12-31
ES2774911T3 (es) 2020-07-23
US9138408B2 (en) 2015-09-22
AU2003253075A1 (en) 2004-01-06
EP2260845A2 (fr) 2010-12-15
JP5041664B2 (ja) 2012-10-03
WO2004000293A2 (fr) 2003-12-31
JP2005535617A (ja) 2005-11-24
MXPA04012641A (es) 2005-08-15
US20050175565A1 (en) 2005-08-11
CN1662229A (zh) 2005-08-31
CA2489308C (fr) 2013-09-03
AU2003253075B2 (en) 2007-07-19
EP2260845A3 (fr) 2012-08-22
EP1515712A2 (fr) 2005-03-23
EP1515712B1 (fr) 2019-12-25

Similar Documents

Publication Publication Date Title
BR0312165A (pt) Utilização da taurina para o tratamento da alopecia
BRPI0204506B8 (pt) aplicação de creatina, creatinina e/ou seus sais
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
BR0313282A (pt) Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
BRPI0519195A2 (pt) composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
TW200637581A (en) Anti-caries oral care composition with a chelating agent
ATE331500T1 (de) Synergistische orale zusammensetzung gegen zahnbelag und gingivitis
BR9911768A (pt) Remédio com efeitos antidepressivos
PT1313489E (pt) Composicoes farmaceuticas para o tratamento de mucosite, estomatite e sindroma de behcet
PL373465A1 (en) Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives
DE60209152D1 (de) Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
DE60312211D1 (de) Haarbehandlungsmittel
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
BR0314844A (pt) Novo composto
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
BR0314843A (pt) Novo composto
BR0313413A (pt) Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer
BR0307056A (pt) Composição farmacêutica orodispersìvel de ivabradina
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano
BR0313177A (pt) Administração oral de calcitonina
PT1362590E (pt) Utilizacao de cilobradina ou dos seus sais farmaceuticamente aceitaveis para o tratamento ou prevencao de falha cardiaca
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
BRPI0406746A (pt) Preparado de combinação contra tontura

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/00 (2006.01), A23L 33/105 (2016.01), A23L 3